Search Results - "Manito, N."

Contribution of Population Pharmacokinetics to Dose Optimization of Ganciclovir-Valganciclovir in Solid-Organ Transplant Patients by Padullés, A, Colom, H, Bestard, O, Melilli, E, Sabé, N, Rigo, R, Niubó, J, Torras, J, Lladó, L, Manito, N, Caldés, A, Cruzado, J M, Grinyó, J M, Lloberas, N

“…Treatment of solid-organ transplant (SOT) patients with ganciclovir (GCV)-valganciclovir (VGCV) according to the manufacturer's recommendations may result in…”
Get full text

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations by Torre-Cisneros, J, Aguado, J.M, Caston, J.J, Almenar, L, Alonso, A, Cantisán, S, Carratalá, J, Cervera, C, Cordero, E, Fariñas, M.C, Fernández-Ruiz, M, Fortún, J, Frauca, E, Gavaldá, J, Hernández, D, Herrero, I, Len, O, Lopez-Medrano, F, Manito, N, Marcos, M.A, Martín-Dávila, P, Monforte, V, Montejo, M, Moreno, A, Muñoz, P, Navarro, D, Pérez-Romero, P, Rodriguez-Bernot, A, Rumbao, J, San Juan, R, Vaquero, J.M, Vidal, E

“…Abstract Cytomegalovirus (CMV) infection remains a major complication of solid organ transplantation. Because of management of CMV is variable among transplant…”
Get full text

Malignancy After Heart Transplantation: Incidence, Prognosis and Risk Factors by Crespo‐Leiro, M. G., Alonso‐Pulpón, L., Vázquez de Prada, J. A., Almenar, L., Arizón, J. M., Brossa, V., Delgado, J. F., Fernandez‐Yañez, J., Manito, N., Rábago, G., Lage, E., Roig, E., Diaz‐Molina, B., Pascual, D., Muñiz, J.

“…The Spanish Post‐Heart‐Transplant Tumour Registry comprises data on neoplasia following heart transplantation (HT) for all Spanish HT patients (1984–2003)…”
Get full text

Health-related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross-sectional study by Delgado, J.F., Almenar, L., González-Vilchez, F., Arizón, J.M., Gómez, M., Fuente, L., Brossa, V., Fernández, J., Díaz, B., Pascual, D., Lage, E., Sanz, M., Manito, N., Crespo-Leiro, M.G.

“…A multicenter cross‐sectional study was conducted to determine the current heart transplant (HTx) outcomes in Spain. Clinical and functional status,…”
Get full text

Consensus on improving the comprehensive care of patients with acute heart failure by Delgado, J., Cepeda, J.M., Llorens, P., Jacob, J., Comín, J., Montero, M., Miró, Ò., López de Sá, E., Manzano, L., Martín-Sánchez, F.J., Formiga, F., Masip, J., Pérez-Calvo, J.I., Herrero-Puente, P., Manito, N.

“…The latest acute heart failure (AHF) consensus document from the Spanish Society of Cardiology (SEC, for its initials in Spanish), Spanish Society of Internal…”
Get full text

Impact of Treatment with m-TOR Inhibitors on Platelet Reactivity in Heart Transplant Patients Treated with Clopidogrel. Preliminary Results by Gonzalez-Costello, J, Ferreiro, J, Roca, J, Marcano, A, Rodríguez, I, Salazar-Mendiguchia, J, Tatjer, I, Miralles, A, Manito, N, Cequier, A

Get full text

Consensus Document of the Spanish Society of Cardiology and the Spanish Society of Internal Medicine on the diagnosis and treatment of iron deficiency in heart failure by Manito, N, Cerqueiro, J M, Comín-Colet, J, García-Pinilla, J M, González-Franco, A, Grau-Amorós, J, Peraira, J R, Manzano, L

Get full text

Donor‐transmitted malaria after heart transplant managed successfully with artesunate by Sabé, N., González‐Costello, J., Oriol, I., Sánchez‐Salado, J.C., Ortega, S., Oliver, E., Manito, N., Carratalà, J.

“…Donor‐transmitted malaria is a rare complication in solid organ transplantation, which causes high mortality. Data concerning the use of artesunate in solid…”
Get full text

Incidence and Risk Factors for Nonmelanoma Skin Cancer After Heart Transplantation by Molina, B.D, Leiro, M.G.C, Pulpón, L.A, Mirabet, S, Yañez, J.F, Bonet, L.A, Vilchez, F.G, Delgado, J.F, Manito, N, Rábago, G, Arizón, J.M, Romero, N, Roig, E, Blasco, T, Pascual, D, de la Fuente, L, Muñiz, J

“…Abstract Introduction The incidence of skin cancer in heart transplant (HT) patients is higher than in the general population, reversing the proportion of…”
Get full text

Outcomes of Heart Transplantation for Cardiac Amyloidosis: Subanalysis of the Spanish Registry for Heart Transplantation by Roig, E., Almenar, L., González‐Vílchez, F., Rábago, G., Delgado, J., Gómez‐Bueno, M., Crespo‐Leiro, M. G., Arizón, J. M., De La Fuente, L., Manito, N.

“…Amyloidosis (Am), a systemic disease, has poor prognosis because of organ damage produced by protein deposition in the extracellular space. Although heart…”
Get full text

Safety of the Use of Prothtombin Complex in Anticoagulated Patients Before Heart Transplantation by González-Costello, J, Couto, D, Domènech, P, Muntané, G, Ortega, S, Roca, J, Salazar-Mendiguchía, J, Miralles, A, Sbraga, F, Cequier, A, Manito, N

Get full text

Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors by Sabé, N, González-Costello, J, Rama, I, Niubó, J, Bodro, M, Roca, J, Cruzado, J M, Manito, N, Carratalà, J

“…Ganciclovir-resistant (GanR) cytomegalovirus (CMV) infection after organ transplantation is emerging as a significant therapeutic challenge. We report two…”
Get more information

Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan by Pose, A, Almenar, L, Manzano, L, Gavira, J J, López Granados, A, Delgado, J, Aramburu, O, Arévalo, J C, Méndez, M, Comín, J, Manito, N

Get full text

Renal Function Improvement After Conversion to Proliferation Signal Inhibitors During Long-Term Follow-up in Heart Transplant Recipients by Kaplinsky, E, González-Costello, J, Manito, N, Roca, J, Barbosa, M.J, Nebot, M, Salazar-Mendiguchia, J, Berdejo, J, Mañas, P, Miralles, A, Cequier, A

“…Abstract Introduction The use of proliferation signal inhibitors (PSIs) for calcineurin-inhibitor (CNI) minimization or conversion protocols has been promoted…”
Get full text

660 Safety Aspects of the Introduction of Everolimus in Cardiac Recipients with Established Allograft Vasculopathy: Results of a Randomized, Multicenter Study by Segovia, J, Palomo, J, González-Vílchez, F, Delgado, J, Brossa, V, Manito, N, Pérez-Villa, F, Rábago, G, Gómez-Bueno, M, Alonso-Pulpón, L

Get full text

339 Clinical Effects of Introducing Everolimus in the Immunosuppressive Regimen of Patients with Established Cardiac Allograft Vasculopathy (CAV): Efficacy Analysis of a Randomized, Multicenter Study by Segovia, J, Fernández-Yáñez, J, González-Vílchez, F.J, Delgado, J, Mirabet, S, Manito, N, Roig, E, Rábago, G, Gómez-Bueno, M, Alonso-Pulpón, L

Get full text

650 High Rate of Discontinuation of a Mammalian Target of Rapamycin Inhibitor Based Regime during Long-Term Follow-Up of Cardiac Transplant Recipients by González-Costello, J, Kaplinsky, E, Manito, N, Roca, J, Nebot, M, Barbosa, M.J, Mañas, P, Salazar, J, Miralles, A, Cequier, A

Get full text

Improvement in Chronic Renal Failure after Mycophenolate Mofetil Introduction and Cyclosporine Dose Reduction: Four-Year Results From a Cohort of Heart Transplant Recipients by Manito, N, Rábago, G, Palomo, J, Arizón, J.M, Delgado, J, Almenar, L, Crespo-Leiro, M.G, Lage, E, Pulpón, L

“…Abstract Chronic renal failure (CRF) due to calcineurin inhibitor (CNI) nephrotoxicity is a frequent complication among heart transplant (HT) recipients. Small…”
Get full text

Risk factors associated with cytomegalovirus infection in heart transplant patients: a prospective, epidemiological study by Delgado, J.F., Manito, N., Almenar, L., Crespo-Leiro, M., Roig, E., Segovia, J., Vázquez de Prada, J.A., Lage, E., Palomo, J., Campreciós, M., Arizón, J.M., Rodríguez-Lambert, J.L., Blasco, T., de la Fuente, L., Pascual, D., Rábago, G.

“…J.F. Delgado, N. Manito, L. Almenar, M. Crespo‐Leiro, E. Roig, J. Segovia, J.A. Vázquez de Prada, E. Lage, J. Palomo, M. Campreciós, J.M. Arizón, J.L…”
Get full text

The falling incidence of hematologic cancer after heart transplantation by Crespo-Leiro, M. G., Delgado-Jiménez, J., López, L., Alonso-Pulpón, L., González-Vilchez, F., Almenar-Bonet, L., Rábago, G., Pérez-Villa, F., Paniagua Martín, M. J., Arizón del Prado, J. M., Sousa-Casasnovas, I., Manito-Lorite, N., Díaz-Molina, B., Pascual-Figal, D., Lage-Galle, E., Blasco-Peiró, T., De la Fuente-Galán, L., Muñiz, J.

“…Background A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post‐HT hematologic cancer, but…”
Get full text